SG
Siddhartha Goutam
University of Calgary, University of Manitoba, Royal College of Physicians and Surgeons of Canada, University of Alberta
0000-0002-5398-2357
Employment
-
University of Calgary Medical Oncology Resident2025 - Present
-
University of Manitoba Internal Medicine Resident2022 - Present
Education
-
Royal College of Physicians and Surgeons of Canada Fellow (Internal Medicine)2026 - Present
-
University of Alberta Doctor of Medicine2018 - Present
-
University of Calgary Bachelor of Health Sciences2014 - 2018
Projects & Funding
Projects & funding information is unavailable.
Publications (17)
- Outcomes and toxicities of immune checkpoint inhibitors in patients with lung cancer and pre-existing autoimmune disease Save
- Neoadjuvant Chemoimmunotherapy for Early Stage Non-Small Cell Lung Cancer: An Observational Population Level Study Save
- An Observational Population Level Study of Neoadjuvant Chemoimmunotherapy for Resectable Non–Small-Cell Lung Cancer Save
- Impact of Performance Status on Survival Outcomes and Health Care Utilization in Patients With Advanced NSCLC Treated With Immune Checkpoint Inhibitors Save
- Treatment-Free Survival After Nivolumab vs Pembrolizumab vs Nivolumab-Ipilimumab for Advanced Melanoma Save
- Development and Validation of a Prognostic Risk Model for Patients with Advanced Melanoma Treated with Immune Checkpoint Inhibitors Save
- Effectiveness of Immune Checkpoint Inhibitor with Anti-PD-1 Monotherapy or in Combination with Ipilimumab in Younger versus Older Adults with Advanced Melanoma Save
- Effectiveness and Safety of Immune Checkpoint Inhibitors in Cancer Patients With Autoimmune Disease: A Retrospective Cohort Study Save
- An Analysis of Clinical and Systemic Factors Associated with Palliative Radiotherapy Delivery and Completion at the End of Life in Alberta, Canada Save
- Association of Immune-Related Adverse Events, Hospitalization, and Therapy Resumption With Survival Among Patients With Metastatic Melanoma Receiving Single-Agent or Combination Immunotherapy Save